These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5511307)

  • 1. [Quantitative and qualitative changes in the level of bile acids in the bile of patients with chronic hepatocholecystitis under the effect of therapy].
    Karbach IaI; Zvershkhanovskiĭ FA
    Ter Arkh; 1970 Dec; 42(12):62-4. PubMed ID: 5511307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of bile salts and cholesterol in the bile of healthy persons and patients with hepatocholecystitis].
    Karbach IaI; Zvershkhanovskiĭ FA
    Vrach Delo; 1971 Mar; 3():50-1. PubMed ID: 5578018
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disorder in mechanisms of bile formation and methods of their correction].
    Iakovenko EP; Grigor'ev PIa; Agafonova NA; Iakovenko AV; Prianishnikova AS
    Eksp Klin Gastroenterol; 2003; (6):32-9. PubMed ID: 15065526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V
    Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
    [No Abstract]   [Full Text] [Related]  

  • 5. [The chologenic and choleretic action of sorbitol].
    Grancharov V
    Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies].
    Hunold W
    Z Allgemeinmed; 1975 Feb; 51(5):237-41. PubMed ID: 1093341
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholagogues and choleretics.
    Hunt T
    Practitioner; 1971 Jan; 206(231):51-5. PubMed ID: 5540194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stachyglen treatment of patients with chronic cholecystitis and cholangitis].
    Peleshchuk AP; Kravchenko AI; Pavlenko KA; Polisskiĭ NM; Iampol'skaia BM
    Vrach Delo; 1974 Jan; (1):65-9. PubMed ID: 4468584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modern concepts of chronic cholecystitis].
    Galkin VA
    Sov Med; 1974; 0(4):45-50. PubMed ID: 4838576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of xylite as a cholagogue].
    Vaĭnshteĭn SG; Maksudova DKh; Pivikova MI
    Klin Med (Mosk); 1970 Jan; 48(1):126-8. PubMed ID: 5419551
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapeutic effect of Urocholesan in acute and chronic cholecystitis].
    Mamchur FI; Vakaliuk PM; Kekalo LA; Neĭko EM
    Vrach Delo; 1969 Oct; 10():3-5. PubMed ID: 5366812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic use of xylith in chronic cholecystitis].
    Kulikova ZS
    Vrach Delo; 1968 Aug; 8():23-5. PubMed ID: 5741738
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of urolesan and phenicarbaran in the combined treatment of chronic cholecystitis].
    Neĭko EM; Skrobach NV
    Vrach Delo; 1985 Jul; (7):13-6. PubMed ID: 4049815
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative evaluation of the therapeutic effect of pequocrin and allochol in chronic cholecystocholangitis].
    Tsimmerman IaS; Mezheborskiĭ AM
    Vrach Delo; 1976; (5):77-82. PubMed ID: 969428
    [No Abstract]   [Full Text] [Related]  

  • 16. The condition of the biliary tract and cholesecretion in cases of ulcerative colitis.
    Abasov IT; Isaev EG; Iof IM
    Hepatogastroenterology; 1985 Jun; 32(3):138-40. PubMed ID: 4018708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of choleretic drug urocholesan in patients with chronic cholecystitis].
    Nemialkovskiĭ IB
    Vrach Delo; 1976 Dec; (12):76-8. PubMed ID: 1014594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effectiveness of stachyren in the treatment of patients with chronic cholecystocholangitis].
    Trusov VV; Varfolomeeva TB; Oreshkov TM; Plastinina RA; Sabsaĭ LG
    Vrach Delo; 1972 Nov; 11():66-9. PubMed ID: 4659743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.